Research Trial for Chronic Hives (40 Weeks)

Males and females aged 18 to 80 with a diagnosis of chronic spontaneous urticaria (hives) for >6 months, may qualify to participate. Looking for Individuals with the presence of itch and hives for >6 consecutive weeks, who are using a defined anti-histamine. Must be naïve to, intolerant of, or an incomplete responder to the drug omalizumab.

Participants will receive investigational medication (active study drug) or placebo, via injection. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided. Participants must be willing and able to complete a daily symptom e-diary for the duration of the study.

Study participation will last about 40 weeks and involve about 5 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Hives
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more